Search Results

You are looking at 21 - 30 of 231 items for :

  • prognostic factor x
  • Refine by Access: All content x
Clear All
Open access

Wenhao Lin, Jun Dai, Jialing Xie, Jiacheng Liu, Fukang Sun, Xin Huang, Wei He, Chen Fang, Juping Zhao, and Danfeng Xu

groups (0–1, 2–3, 4–5, and 6–9) ( 9 ). Development of the model from the SEER dataset Univariable and multivariable Cox proportional hazards regression analyses were applied to select independent prognostic factors for cancer-specific survival

Open access

Anne Jouinot, Juliane Lippert, Martin Fassnacht, Bruno de La Villeon, Amandine Septier, Mario Neou, Karine Perlemoine, Silke Appenzeller, Mathilde Sibony, Sébastien Gaujoux, Bertrand Dousset, Rossella Libe, Lionel Groussin, Cristina L Ronchi, Guillaume Assié, and Jérôme Bertherat

Introduction Adrenocortical carcinoma is a rare cancer with poor but heterogeneous prognosis. The 5-year overall survival of ACC patients remains below 40% in most series ( 1 ). The main prognostic factors used in clinical practice at

Open access

Huy Gia Vuong, Nguyen Phuoc Long, Nguyen Hoang Anh, Tran Diem Nghi, Mai Van Hieu, Le Phi Hung, Tadao Nakazawa, Ryohei Katoh, and Tetsuo Kondo

increased risk for all adverse prognostic factors when compared to classical PTC, except tumor recurrence and patient mortality due to lack of data ( Fig. 3 and Table 2 ). The meta-analyses were consistent among all included studies. Only a small amount of

Open access

Wei Sun, Boyuan Zheng, Zhihong Wang, Wenwu Dong, Yuan Qin, and Hao Zhang

patients could have CCLNM. The outcome of this study is based on soft data (e.g., the presence or absence of metastases in the contralateral central lymph nodes), but not on the recurrence rate or survival. Age is an important prognostic factor for DTC

Open access

Magaly Zappa, Olivia Hentic, Marie-Pierre Vullierme, Matthieu Lagadec, Maxime Ronot, Philippe Ruszniewski, and Valérie Vilgrain

grouped as gastroenteropancreatic neuroendocrine tumours, or GEP-NETs. They are frequently metastasised at diagnosis, and the liver is the most common site of metastases ( 1 ). The presence of liver metastases is a significant negative prognostic factor

Open access

Zeming Liu, Di Hu, Yihui Huang, Sichao Chen, Wen Zeng, Ling Zhou, Wei Zhou, Min Wang, Haifeng Feng, Wei Wei, Chao Zhang, Danyang Chen, and Liang Guo

of tumor foci, tumor extension, N-stage and T-stage were significant prognostic factors. Multivariate analysis using binary logistic regression found that age at diagnosis, N-stage and M-stage were independent prognostic factors for distant metastasis

Open access

Chao-bin He, Yu Zhang, Zhi-yuan Cai, and Xiao-jun Lin

% CI = 1.66–2.03, P  < 0.001) and surgery (HR = 0.24, 95% CI = 0.10–0.62, P  = 0.003) remained independent prognostic factors for OS. Proportional subdistribution hazard assumption was held for variables in CSS analysis. Age (HR = 1.49, 95% CI = 1

Open access

Dirk-Jan van Beek, Rachel S van Leeuwaarde, Carolina R C Pieterman, Menno R Vriens, Gerlof D Valk, and the DutchMEN Study Group

was not always sufficient ( 12 ). Our research group was confronted by a paucity of data on the natural course of the different MEN1 manifestations, prognostic factors, a genotype–phenotype relation, the timing and effect of therapy and

Open access

Pablo Abellán-Galiana, Carmen Fajardo-Montañana, Pedro Riesgo-Suárez, Marcelino Pérez-Bermejo, Celia Ríos-Pérez, and José Gómez-Vela

from 0 to 65.6% (mean 13.2%, median 10.6%) ( 1 , 2 , 3 , 4 , 5 , 6 ). One of the most controversial aspects in the management of CD is the definition of remission criteria ( 7 ) and predictive factors. Different CD remission predictors have

Open access

R C S van Adrichem, L J Hofland, R A Feelders, M C De Martino, P M van Koetsveld, C H J van Eijck, R R de Krijger, D M Sprij-Mooij, J A M J L Janssen, and W W de Herder

Orduna V Sevilla-García I Villabona-Artero C Beguiristain-Gómez A Llanos-Muñoz M . Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer